Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives

被引：53

作者：

Cocco, Maria T. ^{[1
]}

Congiu, Cenzo ^{[1
]}

Lilliu, Valentina ^{[1
]}

Onnis, Valentina ^{[1
]}

机构：

[1] Univ Cagliari, Dipartimento Tossicol, I-09124 Cagliari, Italy

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2007年 / 15卷 / 04期

关键词：

pyridines; dicyanopyridines; anticancer activity; cytostatic activity;

D O I：

10.1016/j.bmc.2006.11.031

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A new series of 2-amino-4-aryl-6-dialkylamino-3,5-dicyanopyridines, 20-47, were synthesized in satisfactory overall yield, through a simple synthetic strategy using 3-amino-3-(dialkylamino)-propenenitriles 1 and 2 as key intermediates. 3,5-Dicyanopyridine derivatives 20-47 were evaluated for their in vitro anticancer activity toward cell lines of nine different types of human cancers. Some of the newly prepared compounds demonstrated inhibitory effects on the growth of a wide range of cancer cell lines generally at 10(-6) M level and in some cases at 10(-8) M concentration. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：1859 / 1867

页数：9

共 21 条

[1]

Anderson David R., 2004, PCT Int. Appl., Patent No. [2004055015, WO 2004055015 A1]

[2] New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist n-ethylcarboxamidoadenosine [J].

Beukers, MW ;

Chang, LCW ;

Künzel, JKVD ;

Mulder-Krieger, T ;

Spanjersberg, RF ;

Brussee, J ;

Ijzerman, AP .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3707-3709

[3]

BOYD M R, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P652

[4] SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].

BOYD, MR ;

PAULI, KD .

DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109

[5]

BOYD MR, 1989, PRINC PRACT ONCOL, V3, P1

[6] A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor [J].

Chang, LCW ;

Künzel, JKVF ;

Mulder-Krieger, T ;

Spanjersberg, RF ;

Roerink, SF ;

van den Hout, G ;

Beukers, MW ;

Brussee, J ;

IJzerman, AP .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :2045-2053

[7]

Chen H., 2005, PCT Int. Appl, Patent No. [WO 2005058315, 2005058315, 2005/058315]

[8] Synthesis and antiproliferative activity of 2,6-dibenzylamino-3,5-dicyanopyridines on human cancer cell lines [J].

Cocco, MT ;

Congiu, C ;

Lilliu, V ;

Onnis, V .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (12) :1365-1372

[9]

COCCO MT, 1991, SYNTHESIS-STUTTGART, P529

[10] One-step, three-component synthesis of pyridines and 1,4-dihydropyridines with manifold medicinal utility [J].

Evdokimov, NM ;

Magedov, IV ;

Kireev, AS ;

Kornienko, A .

ORGANIC LETTERS, 2006, 8 (05) :899-902

← 1 2 3 →